Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Flaminia Antonelli
Observed name:
Flaminia ANTONELLI
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
University of Trieste,
Agostino Gemelli University Polyclinic,
Istituto Dermopatico dell'Immacolata,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-5283-2859
Observed ORCID:
0000-0002-5283-2859
OpenAlex ID:
A5074904135
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets
2022
·
Luca Fania
, Gaia Moretta
, et al.
·
International Journal of Molecular Sciences
·
153
PDF
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
2023
·
Andrea Chiricozzi
, Michela Ortoncelli
, et al.
·
American Journal of Clinical Dermatology
·
63
PDF
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa
2023
·
Dalma Malvaso
, Laura Calabrese
, et al.
·
Pharmaceutics
·
38
PDF
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study
2023
·
Andrea Chiricozzi
, Anna Balato
, et al.
·
Journal of the American Academy of Dermatology
·
33
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study
2024
·
Gianluca Avallone
, Luca Mastorino
, et al.
·
Journal of the American Academy of Dermatology
·
28
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa
2024
·
Laura Calabrese
, Dalma Malvaso
, et al.
·
Biomolecules
·
26
PDF
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients
2021
·
Andrea Chiricozzi
, Niccolò Gori
, et al.
·
Dermatology
·
26
Long‐term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real‐world retrospective study
2024
·
Andrea Chiricozzi
, Niccolò Gori
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
21
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
2024
·
Martina D’Onghia
, Dalma Malvaso
, et al.
·
Journal of Clinical Medicine
·
16
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment
2023
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Clinical and Experimental Dermatology
·
15
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new?
2023
·
Laura Calabrese
, Dalma Malvaso
, et al.
·
Expert Opinion on Investigational Drugs
·
13
PDF
Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
2022
·
Francesco Tassone
, Simone Cappilli
, et al.
·
Vaccines
·
13
PDF
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
2024
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
11
Infectious Adverse Events in Patients with Atopic Dermatitis Treated with Baricitinib
2023
·
Flaminia Antonelli
, Dalma Malvaso
, et al.
·
Immunotherapy
·
11
Melanoma on tattoos: a case study and review of the literature
2022
·
Francesco Ricci
, Luca Fania
, et al.
·
European Journal of Dermatology
·
11
PDF
Factors associated with sunbed use among 3692 outpatients in 18 centers of the Italian Cancer League (LILT)
2021
·
Simona Mastroeni
, Francesca Sampogna
, et al.
·
Scientific Reports
·
10
PDF
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
2025
·
Niccolò Gori
, Marco Galluzzo
, et al.
·
Dermatology
·
6
Efficacy and safety of a combined pharmacological and surgical approach in patients affected by hidradenitis suppurativa: data from a retrospective real-world clinical study
2024
·
Dalma MALVASO
, Andrea CHIRICOZZI
, et al.
·
Italian Journal of Dermatology and Venereology
·
6
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
2023
·
Andrea Chiricozzi
, Michela Ortoncelli
, et al.
·
American Journal of Clinical Dermatology
·
5
PDF
Cutaneous Rosai‐Dorfman disease after Covid 19 vaccination treated with thalidomide
2022
·
Marta Grimaldi
, Francesca Perino
, et al.
·
Dermatologic Therapy
·
5
PDF
Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa
2022
·
Luca Fania
, Giulia Giovanardi
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study
2023
·
Flaminia Antonelli
, Elena Ippoliti
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
2021
·
Andrea Chiricozzi
, Lucia Di Nardo
, et al.
·
Dermatitis
·
4
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors
2025
·
Niccolò Gori
, Lucia Di Nardo
, et al.
·
Journal of Dermatological Treatment
·
3
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay
2026
·
Anna Pira
, Adele Salemme
, et al.
·
Journal of the American Academy of Dermatology
·
1
Show more works
View as search
Works count:
30
Citation count:
530
H-index:
12
I10-index:
16
Year
Topic
Type